193 related articles for article (PubMed ID: 33934537)
1. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
2. Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.
Macios A; Komerska K; Nowakowski A
Cancer Med; 2023 Jun; 12(12):13800-13810. PubMed ID: 37211978
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
Thipsanthiah K; Kamsa-Ard S; Musika W; Teemuangsai W; Hawlader MDH
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3429-3436. PubMed ID: 37898847
[TBL] [Abstract][Full Text] [Related]
4. Why are Polish women diagnosed with invasive cervical cancer after negative cytology in the organized screening programme - a pilot reevaluation of negative Pap smears preceding diagnoses of interval cancers.
Komerska K; Macios A; Glińska P; Olszewski W; Didkowska J; Wojciechowska U; Kamiński MF; Nowakowski A
Pol J Pathol; 2021; 72(3):261-266. PubMed ID: 35048639
[TBL] [Abstract][Full Text] [Related]
5. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
6. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
7. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
8. Pap tests in the diagnosis of cervical cancer: Help or hinder?
Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
[TBL] [Abstract][Full Text] [Related]
9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
10. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
[TBL] [Abstract][Full Text] [Related]
11. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
[TBL] [Abstract][Full Text] [Related]
12. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
13. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
14. Factors related to inter-observer reproducibility of conventional Pap smear cytology: a multilevel analysis of smear and laboratory characteristics.
Baena A; Guevara E; Almonte M; Arias-Stella J; Sasieni P; Sanchez GI
Cytopathology; 2017 Jun; 28(3):192-202. PubMed ID: 28029192
[TBL] [Abstract][Full Text] [Related]
15. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
16. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
17. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
18. Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trial.
Kolben TM; Bergauer F; Moeckel J; Boettcher B; Thaler CJ; Kolben T; Crispin A; Dannecker C; Mahner S; Gallwas J
Arch Gynecol Obstet; 2017 Jun; 295(6):1427-1433. PubMed ID: 28405743
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
20. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
